Nutex Health CEO to Be a Panel Speaker at the 2023 McDermott and Ey Healthcare Meeting in San Francisco

Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced that Tom Vo, M.D., MBA (CEO and Chairman) will be a panel speaker at the McDermott and EY Meeting on January 10, 2023 at the 2023 J.P. Morgan Healthcare Conference in San Francisco, California. The Panel is titled: Hospital and Health System Innovation and Transformation.

The 2023 Meeting is hosted by McDermott Will & Emery and EY. Dr. Vo is a previous winner of the EY Entrepreneur of The Year Award and is honored to share his knowledge and experience on the panel.

The conference aims to connect senior leaders and build new partnerships in healthcare, life sciences, and private equity.

For more information on the event, visit McDermott and EY at the 2023 J.P. Morgan Healthcare Conference (

The Nutex Health management team will also be presenting at the 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023:

About Nutex Health Inc.

Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division. The Hospital Division owns, develops, and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 21 facilities in 8 states.

The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our Management Services Organization (MSO), we provide management, administrative and other support services to our affiliated hospitals and physician groups. Our cloud-based proprietary technology platform aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers, allowing us to deliver greater quality care more efficiently.


Written by Nizel Pradhan

Element CEO and Co-Founder Molly He to Speak at 41st Annual J.P. Morgan Healthcare Conference

Monica Shaw appointed CEO of Oncopeptides – Jakob Lindberg assumes position as Chief Scientific Officer